Staffan Svensson

Summary

Country: Sweden

Publications

  1. ncbi Reasons for adherence with antihypertensive medication
    S Svensson
    Department of Clinical Pharmacology, Sahlgrenska University Hospital, SE 413 45, Gothenburg, Sweden
    Int J Cardiol 76:157-63. 2000
  2. ncbi Adverse events and patients' perceptions of antihypertensive drug effectiveness
    S Svensson
    Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hum Hypertens 17:671-5. 2003
  3. ncbi Escitalopram: superior to citalopram or a chiral chimera?
    Staffan Svensson
    Department of Clinical Pharmacology, Sahlgren s University Hospital, Gothenburg, Sweden Healthy Skepticism Inc, Willunga, Australia
    Psychother Psychosom 73:10-6. 2004
  4. ncbi Patient perceptions of hypertension and its treatment
    Staffan Svensson
    Blood Press 12:5-6. 2003
  5. ncbi Drug advertising in medical journals
    Peter R Mansfield
    Lancet 361:879. 2003
  6. ncbi Making sense of blood pressure values in follow-up appointments for hypertension
    Staffan Svensson
    Department of Clinical Pharmacology, Sahlgrenska Academy at Goteborg University, SE 413 45 Gothenburg, Sweden
    Int J Cardiol 123:108-16. 2008

Detail Information

Publications6

  1. ncbi Reasons for adherence with antihypertensive medication
    S Svensson
    Department of Clinical Pharmacology, Sahlgrenska University Hospital, SE 413 45, Gothenburg, Sweden
    Int J Cardiol 76:157-63. 2000
    ..Little is known about the underlying reasons for poor adherence. We set out to investigate hypertensive patients' self-reported reasons for adhering to or ignoring medical advice regarding antihypertensive medication...
  2. ncbi Adverse events and patients' perceptions of antihypertensive drug effectiveness
    S Svensson
    Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hum Hypertens 17:671-5. 2003
    ..Possible explanations for these findings are pre-existing differences in attitude towards drugs and level of fear of complications...
  3. ncbi Escitalopram: superior to citalopram or a chiral chimera?
    Staffan Svensson
    Department of Clinical Pharmacology, Sahlgren s University Hospital, Gothenburg, Sweden Healthy Skepticism Inc, Willunga, Australia
    Psychother Psychosom 73:10-6. 2004
    ..The manufacturer claims that escitalopram has more efficacy and a faster onset of effect than citalopram. The purpose of this study was to assess how far these claims are justified...
  4. ncbi Patient perceptions of hypertension and its treatment
    Staffan Svensson
    Blood Press 12:5-6. 2003
  5. ncbi Drug advertising in medical journals
    Peter R Mansfield
    Lancet 361:879. 2003
  6. ncbi Making sense of blood pressure values in follow-up appointments for hypertension
    Staffan Svensson
    Department of Clinical Pharmacology, Sahlgrenska Academy at Goteborg University, SE 413 45 Gothenburg, Sweden
    Int J Cardiol 123:108-16. 2008
    ..This may be a function of how patients and physicians put measured values into context when they decide if the blood pressure is well controlled or too high...